|
|
|
1-10 employees
View all
|
|
Biotechnology
|
|
201 E Fifth Street, Suite 1900, Cincinnati, Ohio 45202, US
|
|
Blue Water Vaccines (Nasdaq: BWV) is a biopharmaceutical company focused on developing transformational vaccines to address significant health challenges globally. The company holds the rights to proprietary technology developed at the University of Oxford, Cincinnati Children's Hospital Medical Center (CCHMC), and St. Jude Children's Hospital. The company is developing a universal flu vaccine that will provide protection from all virulent strains in addition to licensing a novel norovirus (NoV) S&P nanoparticle versatile virus-like particle (VLP) vaccine platform from CCHMC to develop vaccines for multiple infectious diseases, including norovirus/rotavirus and malaria, among others. Additionally, Blue Water Vaccines is developing a Streptococcus pneumoniae (pneumococcus) vaccine candidate, designed to specifically prevent the highly infectious middle ear infections, known as Acute Otitis Media (AOM), in children.
|
Blue Water Vaccines Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Blue Water Vaccines Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Blue Water Vaccines Inc. customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.